Status:
NOT_YET_RECRUITING
InRAD Observational Study
Lead Sponsor:
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Collaborating Sponsors:
InRAD Foundation (Data Processor)
All Individual Principal Investigators and their centers (Data Controllers)
Conditions:
Alzheimer's Disease(AD)
Mild Cognitive Impairment (MCI)
Eligibility:
All Genders
Brief Summary
The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine ...
Detailed Description
The study protocol is owned by all InRAD Observational Study Investigators. All centers taking part in InRAD are the data controllers. InRAD is a data processor and is providing operational management...
Eligibility Criteria
Inclusion
- Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR
- Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated),
- Be attending an InRAD Center,
- Have provided informed consent for long-term follow-up
Exclusion
- Any patient or legal representative who is unable or unwilling to provide a signed informed consent form
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2036
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT07213700
Start Date
January 1 2026
End Date
January 1 2036
Last Update
October 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.